<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34564799</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2579</StartPage><EndPage>2587</EndPage><MedlinePgn>2579-2587</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05634-z</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of our study was to investigate the genetic characteristics in patients with familial or young-onset amyotrophic lateral sclerosis (ALS) in a Chinese center.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with familial or young-onset (age of onset&#x2009;&lt;&#x2009;45&#xa0;years old) ALS were reviewed. The clinical data was collected. Whole-exome sequencing was performed to identify the disease-associated variants. Single-nucleotide variants and small insertions/deletions were further predicted with silico tools and compared to the Single Nucleotide Polymorphism Database, Exome Aggregation Consortium, and the 1000 Genomes Project. The evolutionary conservations were estimated, and the structures of proteins were constructed by Swiss-Model server. Immunohistochemistry was used to confirm the misfolded SOD1 protein.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three familial ALS and 5 young-onset ALS were enrolled. Genetic analysis identified related variants of SOD1 (4/6, 66.7%), FUS (1/6, 16.7%), and NEK1 (1/6, 16.7%) in 6 patients. Three of them were familial probands (3/3, 100%), and the others were sporadic young-onset patients (3/5, 60%). NEK1 c.290G&#x2009;&gt;&#x2009;A mutation (NM_012224.2 exon4) in a patient with familial ALS and SOD1 c.362A&#x2009;&gt;&#x2009;G mutation (NM_000454 exon5) in a young-onset ALS patient were novel. The novel mutations were predicted to be deleterious, affected evolutionarily highly conserved amino acid residue and the formation of hydrogen bonds between the mutated site and its surrounding amino acid residues. Misfolded SOD1 protein was identified in patient with SOD1 c.362A&#x2009;&gt;&#x2009;G mutation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Two novel mutations were detected in our patients. Patients with familial or young-onset ALS often carried related gene mutations, and genetic sequencing should be thus routinely performed.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Rongjuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Xueli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Junhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Hospital, Shanxi Medical University, No.85, Jiefang South Street, Taiyuan, 030000, People's Republic of China. zhangvey@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>201704D13111584</GrantID><Agency>ShanXi Science and Technology Department</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Neurol Sci. 2022 Jan 22;:</RefSource><PMID Version="1">35064862</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">Genetic mutations</Keyword><Keyword MajorTopicYN="N">NEK1</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>26</Day><Hour>21</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34564799</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05634-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05634-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es M et al (2017) Amyotrophic lateral sclerosis. Lancet 390(10107):2084&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R, Al-Chalabi AJTNEjom (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A, Chi&#xf2; A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N et al (2016) Recent advances in amyotrophic lateral sclerosis. J Neurol 263(6):1241&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">27025851</ArticleId><ArticleId IdType="pmc">4893385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJTLN (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">25700176</ArticleId><ArticleId IdType="pmc">4437632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M et al (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C et al (2016) De novo FUS P525L mutation in juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol Genet 2(2):e63</Citation><ArticleIdList><ArticleId IdType="pubmed">27123482</ArticleId><ArticleId IdType="pmc">4830191</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson C, Al-Chalabi A (2006) Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta 1762(11&#x2013;12):973&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">16973338</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A et al (2010) An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81(12):1324&#x2013;1326</Citation><ArticleIdList><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O et al (2012) ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat 33(9):1345&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A et al (2012) ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J Neurol Neurosurg Psychiatry 83(7):730&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pubmed">22550220</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M et al (2012) Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 21(17):3776&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigetti M et al (2011) SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Neurobiol Aging 32(10):1924.e15&#x2013;8</Citation></Reference><Reference><Citation>Turner M et al (2012) Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain 135(Pt 9):2883&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pubmed">22661746</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 5:293&#x2013;9</Citation></Reference><Reference><Citation>de Carvalho M et al (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119(3):497&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S et al (2012) Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 79(1):66&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pubmed">22722621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M et al (2011) Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS. Amyotroph Lateral Scler 12(4):278&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">21702734</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34(6):404&#x2013;423</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z et al (2019) Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis 10(6):1199&#x2013;1206</Citation><ArticleIdList><ArticleId IdType="pubmed">31788332</ArticleId><ArticleId IdType="pmc">6844596</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q et al (2016) Mutation spectrum of Chinese patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 87(11):1272&#x2013;1274</Citation><ArticleIdList><ArticleId IdType="pubmed">27313233</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C et al (2011) FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. Neurobiol Aging 32(3):553.e13&#x2013;21</Citation></Reference><Reference><Citation>Zou Z et al (2016) The distinctive genetic architecture of ALS in mainland China. J Neurol Neurosurg Psychiatry 87(8):906&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">26519472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L et al (2016) Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China. Sci Rep 6:32478</Citation><ArticleIdList><ArticleId IdType="pubmed">27604643</ArticleId><ArticleId IdType="pmc">5015023</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S et al (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet 47(8):554&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">20577002</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J et al (2019) Novel and recurrent mutations in a cohort of Chinese patients with young-onset amyotrophic lateral sclerosis. Front Neurosci 13:1289</Citation><ArticleIdList><ArticleId IdType="pubmed">31866807</ArticleId><ArticleId IdType="pmc">6908997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S et al (2019) Genetics of amyotrophic lateral sclerosis: A review. J Neurol Sci 399:217&#x2013;226</Citation><ArticleIdList><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Conte A, Zollino M (2013) Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin Genet 83(5):408&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">23379621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Ando Y (2015) Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener 4:13</Citation><ArticleIdList><ArticleId IdType="pubmed">26213621</ArticleId><ArticleId IdType="pmc">4513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ et al (2017) The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet 92(3):267&#x2013;273</Citation><ArticleIdList><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HX et al (2019) Identification and functional analysis of novel mutations in the SOD1 gene in Chinese patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20(3&#x2013;4):222&#x2013;228</Citation><ArticleIdList><ArticleId IdType="pubmed">30887850</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JA et al (2012) SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph Lateral Scler 13(2):217&#x2013;222</Citation><ArticleIdList><ArticleId IdType="pubmed">22292843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelko IN, Mariani TJ, Folz RJ (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33(3):337&#x2013;49</Citation><ArticleIdList><ArticleId IdType="pubmed">12126755</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Aquilina JA, Yerbury JJ (2016) Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity. Front Neurosci 10:499</Citation><ArticleIdList><ArticleId IdType="pubmed">27867347</ArticleId><ArticleId IdType="pmc">5095133</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffmo KS et al (2013) Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Hum Mol Genet 22(1):51&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">23026746</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE et al (2012) Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS. Proc Natl Acad Sci U S A 109(14):5505&#x2013;5510</Citation><ArticleIdList><ArticleId IdType="pubmed">22431618</ArticleId><ArticleId IdType="pmc">3325721</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405&#x2013;424</Citation><ArticleIdList><ArticleId IdType="pubmed">25741868</ArticleId><ArticleId IdType="pmc">4544753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z et al (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88(7):540&#x2013;549</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z et al (2016) Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener 17(3&#x2013;4):249&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">26972116</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208&#x2013;1211</Citation><ArticleIdList><ArticleId IdType="pubmed">19251628</ArticleId><ArticleId IdType="pmc">4516382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair I et al (2010) FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry 81(6):639&#x2013;45</Citation><ArticleIdList><ArticleId IdType="pubmed">19965854</ArticleId></ArticleIdList></Reference><Reference><Citation>Syriani E, Morales M, Gamez J (2011) FUS/TLS gene mutations are the second most frequent cause of familial ALS in the Spanish population. Amyotroph Lateral Scler 12(2):118&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">21128870</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bers A et al (2015) De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol Aging 36(11):3117.e1&#x2013;3117.e6</Citation></Reference><Reference><Citation>Zou Z et al (2013) De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol Aging 34(4):1312.e1&#x2013;8</Citation></Reference><Reference><Citation>Wheway G et al (2015) An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nat Cell Biol 17(8):1074&#x2013;1087</Citation><ArticleIdList><ArticleId IdType="pubmed">26167768</ArticleId><ArticleId IdType="pmc">4536769</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X et al (2015) The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Biochim Biophys Sin (Shanghai) 47(10):834&#x2013;841</Citation></Reference><Reference><Citation>Yang Y et al (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29(2):160&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y et al (2020) Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant. Ann Clin Transl Neurol 7(6):965&#x2013;971</Citation><ArticleIdList><ArticleId IdType="pubmed">32462798</ArticleId><ArticleId IdType="pmc">7318098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>